Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Nagaoki Toyoda"'
Autor:
Shosaku Nomura, Akira Shouzu, Takehito Taniura, Yoshinori Okuda, Seitaro Omoto, Masahiko Suzuki, Tomoki Ito, Nagaoki Toyoda
Publikováno v:
Clinical Pharmacology: Advances and Applications. 15:41-55
Shosaku Nomura,1 Akira Shouzu,2 Takehito Taniura,3 Yoshinori Okuda,4 Seitaro Omoto,5 Masahiko Suzuki,6 Tomoki Ito,7 Nagaoki Toyoda8 1Center of Thrombosis and Hemostasis, Kansai Medical University Medical Center, Moriguchi, Japan; 2Division of Diabete
Autor:
Mitsushige Nishikawa, Azusa Maruoka, Mikiko Okazaki-Hada, Nagaoki Toyoda, Akira Miyauchi, Mitsuru Ito, Mitsuyoshi Hirokawa, Takashi Akamizu, Masatoshi Yamamoto
Publikováno v:
Thyroid.
Background: Poorly differentiated thyroid carcinoma is rare and patients are typically euthyroid. We report a novel rare case of poorly differentiated thyroid carcinoma with triiodothyronine (T3) t...
Autor:
Nagaoki Toyoda, Mitsuru Ito, Azusa Harada, Kumiko Nishimura, Akira Miyauchi, Emiko Nomura, Hiroshi Yoshida, Ichiro Shiojima, Mitsushige Nishikawa
Publikováno v:
Endocrine. 64:584-590
The serum free triiodothyronine (FT3)/free thyroxine (FT4) ratio in patients with huge goitrous Hashimoto’s thyroiditis (HG-HT) is relatively high. We investigated the cause of high FT3/FT4 ratios. We measured the serum FT3, FT4, and thyrotropin (T
Autor:
Hirotoshi Nakamura, Toshihiko Kasahara, Waka Yoshioka, Eijun Nishihara, Mitsuru Ito, Shuji Fukata, Mitsushige Nishikawa, Kazuyoshi Kousaka, Akira Miyauchi, Hirosuke Danno, Nagaoki Toyoda, Takumi Kudo, Motoki Kawasaki, Tomohiko Nakamura
Publikováno v:
Endocrine journal. 66(9)
While patients with large goitrous thyroid diseases often have a relatively high serum free triiodothyronine (FT3)/free thyroxine (FT4) ratio, athyreotic patients have a relatively low FT3/FT4 ratio. Here we investigated the relationship between thyr
Autor:
Keita Horitani, Kumiko Nishimura, Masayoshi Iwasaki, C Ukita, Nagaoki Toyoda, Kensaku Wada, Hiroshi Kishimoto, K Takahashi, Ichiro Shiojima
Publikováno v:
European Heart Journal. 39
Publikováno v:
Life sciences. 203
Aims Type 3 iodothyronine deiodinase (D3), which converts thyroxine (T4) and 3,5,3′-triiodothyronine (T3) to 3,3′,5′-triiodothyronine (rT3) and 3,3′-diiodothyronine (T2), respectively, inactivates thyroid hormones. We investigated the express
Autor:
Makiko Kusabe, Tatsuyori Morita, Nobuyuki Takahashi, Fusakazu Jo, Maiko Seo, Hiroko Ueda, Mitsutaka Nakahigashi, Rika Kubo, Ichiro Shiojima, Satoshi Morimoto, Yoshiki Okuno, Kazunori Someya, Chikara Nakano, Nagaoki Toyoda, Toshiji Iwasaka
Publikováno v:
Internal Medicine. 53:307-314
OBJECTIVE Dyslipidemia is a risk factor for not only cardiovascular diseases (CVD), but also chronic kidney disease (CKD). Ezetimibe, a cholesterol absorption inhibitor, lowers cholesterol levels by inhibiting both extrinsic and intrinsic cholesterol
Autor:
Chin-Yi Yeh, Zsuzsanna Major, Oskar Zakiyanov, Tomáš Zima, Barbara Varga-Pintér, Z. Mustapic, Christopher W. McIntyre, Stewart H. Lambie, Idris Guessous, Z. Kastelan, G. Jensen, Satz Mengensatzproduktion, Lucia Klimcakova, P. Kes, Shih-Wei Chang, Günther Kundt, Hideaki Shima, Yu-Chuan Tsai, Toshihide Naganuma, Francisco J.B. Sampaio, Masaaki Inaba, E. Nowakowska-Fortuna, Tatsuya Nakatani, Makiko Kusabe, Richard Fluck, Takeshi Yamasaki, Célia Martins Cortez, Atsushi Kosaki, Dilson Silva, Tatsuyori Morita, Vladimír Tesař, Mitsuru Ichii, Waldemar S. Costa, Hiromi Jo, A. Alhadad, Claudia Jensen, Mitsushige Nishikawa, Druck Reinhardt Druck Basel, Jun Neng Roan, Jana Behunova, Ludmila Podracka, Maarten W. Taal, Birgit Salewski, Nagaoki Toyoda, Patrícia Horváth, A. Saeed, Murielle Bochud, Lj. Bubic-Filipi, Vítězslav Kříha, Fusakazu Jo, A. Gottsäter, U. Nilsson, Ya-Fen Jiangshieh, Dieter Haffner, I. Mattiasson, Aghogho Odudu, Michel Burnier, Toshiji Iwasaka, Olivier Bonny, B. Lindblad, Marta Kalousová, N. Basic-Jukic, Diogo Benchimol de Souza, Satoshi Morimoto, Patrick C. D’Haese, Gábor Pavlik, G. Guron, Eiji Ishimura, Geert J. Behets, Kazunori Someya, V. Lovcic, Anja Rahn, I. Mokos, Takanobu Imada, Dagmar-Christiane Fischer, Chen-Fuh Lam, H. Herlitz, Camila Marinho Costa Silva, Péter Osváth, Zsuzsanna Kneffel, Wen-Cheng Chiu, Mitsutaka Nakahigashi, Chou-Hwei Lee, S. Zekan, Katsuhito Mori
Publikováno v:
Kidney and Blood Pressure Research. 34:I-V
Autor:
Akira Miyauchi, Nagaoki Toyoda, Yuuki Takamura, Junta Takamatsu, Mitsuru Ito, Toshiji Iwasaka, Mitsushige Nishikawa, Nobuyuki Amino, Emiko Nomura
Publikováno v:
European Journal of Endocrinology. 164:95-100
Objective3,5,3′-triiodothyronine-predominant Graves' disease (T3-P-GD) is characterized by a persistently high serum T3 level and normal or even lower serum thyroxine (T4) level during antithyroid drug therapy. The source of this high serum T3 leve
Autor:
Tatsuyori Morita, Nobuyuki Takahashi, Nagaoki Toyoda, Satoshi Morimoto, Toshiji Iwasaka, Kazunori Someya
Publikováno v:
Integrated blood pressure control
Rigid control of blood pressure (BP) is essential to prevent cardiovascular disease. However, only about 40% of hypertensive patients undergoing pharmacological intervention with a single agent achieve their BP goals in contemporary clinical practice